Embarking on a journey of policy experimentation might be easier with just a first small step… Keen to encourage a culture of experimentation amongst policy makers, IGL has been examining the barriers that prevent its adoptions – finding that these include a reluctance to disrupt the status quo, fears of a backlash if ‘lotteries’ are used to allocate support or simply that evaluation is considered too late.
Read the latest blogs from the IGL network.
Last December we co-hosted our winter Research Meeting at Harvard Business School, together with Professors Karim Lakhani and Rembrand Koning. Over 50 researchers were welcomed for a day packed with eight presentations of early-stage, ongoing and completed randomised controlled trials (RCTs).
Randomised Control Trials (RCTs) are considered by many to be the gold standard in demonstrating the real impact of an intervention such as the introduction of a new medicine; but translating the approach to the social sciences is not without challenges. Within the field of public policy, conducting an RCT can be viewed as a challenge to traditional institutional practices, raise ethical and political concerns, and be too complex for non-expert staff to design and implement.
What prevents government agencies from making a greater use of randomised controlled trials (RCTs), as well as evidence to inform their policies? Last summer we set out to answer this question, and to try and tease out which barrier is the most important. In this blog we present the results from our survey.
IGL is undertaking a study on the barriers that prevent organisations from using randomised controlled trials to evaluate programmes and, more generally, using evidence to inform policies. Take part in our survey to give us your perspective.
On May 24-26 we welcomed over 200 senior policy makers, practitioners and researchers working in innovation, entrepreneurship and growth policy at the IGL Conference. Here are three quick takeaways from the events.
As more and more governments attempt to base their policies on sound evidence, randomised controlled trials - the 'gold standard' in evaluation - are gaining a stronger role in determining which policies work. But are they really the best way to tell us which policies should be used? This blogpost explores how to improve our ability to learn and better design things that work.
Our estimates for the spending on business support across the European Union, based on our research for the UK, indicate that as much as €152 billion were spent in 2014. In this blog, we explore what this means for Europe, and what could be done better.